Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23


Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in France.

Vukusic S, Rollot F, Casey R, Pique J, Marignier R, Mathey G, Edan G, Brassat D, Ruet A, De Sèze J, Maillart E, Zéphir H, Labauge P, Derache N, Lebrun-Frenay C, Moreau T, Wiertlewski S, Berger E, Moisset X, Rico-Lamy A, Stankoff B, Bensa C, Thouvenot E, Heinzlef O, Al-Khedr A, Bourre B, Vaillant M, Cabre P, Montcuquet A, Wahab A, Camdessanché JP, Tourbah A, Guennoc AM, Hankiewicz K, Patry I, Nifle C, Maubeuge N, Labeyrie C, Vermersch P, Laplaud DA; OFSEP Investigators.

JAMA Neurol. 2019 Sep 3. doi: 10.1001/jamaneurol.2019.2670. [Epub ahead of print]


Re: 'Microbiological epidemiology depending on time to occurrence of prosthetic joint infection' by Triffault-Fillit et al.

Bohard L, Patry I, Sergent P, Leroy J, Chirouze C, Bouiller K.

Clin Microbiol Infect. 2020 Feb;26(2):260-261. doi: 10.1016/j.cmi.2019.08.012. Epub 2019 Aug 29. No abstract available.


Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis.

Laplaud DA, Casey R, Barbin L, Debouverie M, De Sèze J, Brassat D, Wiertlewski S, Brochet B, Pelletier J, Vermersch P, Edan G, Lebrun-Frenay C, Clavelou P, Thouvenot E, Camdessanché JP, Tourbah A, Stankoff B, Al Khedr A, Cabre P, Lubetzki C, Papeix C, Berger E, Heinzlef O, Debroucker T, Moreau T, Gout O, Bourre B, Wahab A, Labauge P, Magy L, Defer G, Guennoc AM, Maubeuge N, Labeyrie C, Patry I, Nifle C, Casez O, Michel L, Rollot F, Leray E, Vukusic S, Foucher Y; SFSEP and OFSEP groups.

Neurology. 2019 Aug 13;93(7):e635-e646. doi: 10.1212/WNL.0000000000007938. Epub 2019 Jul 12.


Inventory of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in France as Assessed by a Multicenter Study.

Robin F, Beyrouthy R, Bonacorsi S, Aissa N, Bret L, Brieu N, Cattoir V, Chapuis A, Chardon H, Degand N, Doucet-Populaire F, Dubois V, Fortineau N, Grillon A, Lanotte P, Leyssene D, Patry I, Podglajen I, Recule C, Ros A, Colomb-Cotinat M, Ponties V, Ploy MC, Bonnet R.

Antimicrob Agents Chemother. 2017 Feb 23;61(3). pii: e01911-16. doi: 10.1128/AAC.01911-16. Print 2017 Mar.


Appropriateness of aminoglycoside prescriptions in a French university hospital.

Muller A, Leroy J, Patry I, Hénon T, Hocquet D, Chirouze C, Bertrand X.

Med Mal Infect. 2016 Sep;46(6):308-13. doi: 10.1016/j.medmal.2016.04.009. Epub 2016 May 24.


Amino Acid Substitutions Account for Most MexS Alterations in Clinical nfxC Mutants of Pseudomonas aeruginosa.

Richardot C, Juarez P, Jeannot K, Patry I, Plésiat P, Llanes C.

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2302-10. doi: 10.1128/AAC.02622-15. Print 2016 Apr.


Surgical antibiotic prophylaxis compliance in a university hospital.

Muller A, Leroy J, Hénon T, Patry I, Samain E, Chirouze C, Bertrand X.

Anaesth Crit Care Pain Med. 2015 Oct;34(5):289-94. doi: 10.1016/j.accpm.2015.04.004. Epub 2015 Sep 15.


Decline in antibiotic resistance and changes in the serotype distribution of Streptococcus pneumoniae isolates from children with acute otitis media; a 2001-2011 survey by the French Pneumococcal Network.

Kempf M, Varon E, Lepoutre A, Gravet A, Baraduc R, Brun M, Chardon H, Cremniter J, Croizé J, Dalmay F, Demachy MC, Fosse T, Grelaud C, Hadou T, Hamdad F, Koeck JL, Luce S, Mermond S, Patry I, Péchinot A, Raymond J, Ros A, Segonds C, Soullié B, Tandé D, Vergnaud M, Vernet-Garnier V, Wallet F, Gutmann L, Ploy MC, Lanotte P.

Clin Microbiol Infect. 2015 Jan;21(1):35-42. doi: 10.1016/j.cmi.2014.08.009. Epub 2014 Oct 12.


Evolving epidemiology and antimicrobial resistance in spontaneous bacterial peritonitis: a two-year observational study.

Piroth L, Pechinot A, Di Martino V, Hansmann Y, Putot A, Patry I, Hadou T, Jaulhac B, Chirouze C, Rabaud C, Lozniewski A, Neuwirth C, Chavanet P, Minello A.

BMC Infect Dis. 2014 May 23;14:287. doi: 10.1186/1471-2334-14-287.


Diagnosis and management of nocardiosis after bone marrow stem cell transplantation in adults: lack of lymphocyte recovery as a major contributing factor.

Mansi L, Daguindau E, Saas P, Pouthier F, Ferrand C, Dormoy A, Patry I, Garnache F, Rohrlich PS, Deconinck E, Larosa F.

Pathol Biol (Paris). 2014 Jun;62(3):156-61. doi: 10.1016/j.patbio.2014.04.001. Epub 2014 May 27.


Streptococcus bovis/Streptococcus equinus complex fecal carriage, colorectal carcinoma, and infective endocarditis: a new appraisal of a complex connection.

Chirouze C, Patry I, Duval X, Baty V, Tattevin P, Aparicio T, Pagenault M, Carbonnel F, Couetdic G, Hoen B.

Eur J Clin Microbiol Infect Dis. 2013 Sep;32(9):1171-6. doi: 10.1007/s10096-013-1863-3. Epub 2013 Apr 6.


Appropriate use of carbapenems in the Besançon university hospital.

Jary F, Kaiser JD, Henon T, Leroy J, Patry I, Blasco G, Limat S.

Med Mal Infect. 2012 Oct;42(10):510-6. doi: 10.1016/j.medmal.2012.07.004. Epub 2012 Oct 6.


Role of the MexEF-OprN efflux system in low-level resistance of Pseudomonas aeruginosa to ciprofloxacin.

Llanes C, Köhler T, Patry I, Dehecq B, van Delden C, Plésiat P.

Antimicrob Agents Chemother. 2011 Dec;55(12):5676-84. doi: 10.1128/AAC.00101-11. Epub 2011 Sep 12.


[Antibiotics in elderly patients: Impact of clinical practice evaluation].

Raymond S, Bourdelin M, Becker M, Henon T, Patry I, Leroy J, Limat S.

Med Mal Infect. 2011 Jun;41(6):330-5. doi: 10.1016/j.medmal.2011.02.002. Epub 2011 Mar 22. French.


Bacterial epidemiology and antimicrobial resistance in ascitic fluid: a 2-year retrospective study.

Piroth L, Pechinot A, Minello A, Jaulhac B, Patry I, Hadou T, Hansmann Y, Rabaud C, Chavanet P, Neuwirth C.

Scand J Infect Dis. 2009;41(11-12):847-51. doi: 10.3109/00365540903244535.


[Regional audit on fluoroquinolones usage in the hospital and the community: are these antibiotics over-used?].

Leroy J, Patry I, Faure C, Ariskina E, Gaume JP, Hénon T, Ruyer O, Faller JP, Hoen B, Bertrand X, Talon D.

Pathol Biol (Paris). 2011 Oct;59(5):e103-7. doi: 10.1016/j.patbio.2009.09.002. Epub 2009 Nov 5. French.


[Evaluation of antibiotic prescription in a French university hospital].

Patry I, Leroy J, Hénon T, Talon D, Hoen B, Bertrand X.

Med Mal Infect. 2008 Jul;38(7):378-82. doi: 10.1016/j.medmal.2008.03.009. Epub 2008 Jun 18. French.


Are antibiotic-resistant Pseudomonas aeruginosa isolated from hospitalised patients recovered in the hospital effluents?

Tuméo E, Gbaguidi-Haore H, Patry I, Bertrand X, Thouverez M, Talon D.

Int J Hyg Environ Health. 2008 Mar;211(1-2):200-4. Epub 2007 Apr 24.


Patient and bacterial determinants involved in symptomatic urinary tract infection caused by Escherichia coli with and without bacteraemia.

Venier AG, Talon D, Patry I, Mercier-Girard D, Bertrand X.

Clin Microbiol Infect. 2007 Feb;13(2):205-208. doi: 10.1111/j.1469-0691.2006.01586.x.


[Surveillance of antimicrobial resistance and antimicrobial use in a university-affiliated hospital: implementation of a computerized system].

Muller A, Patry I, Talon D, Cornette C, Lopez-Lozano JM, Plésiat P, Bertrand X.

Pathol Biol (Paris). 2006 Mar;54(2):112-7. French.


[Low-level resistance to fluoroquinolones conferred by efflux overproduction in Pseudomonas aeruginosa: clinical significance and routine detection].

Hocquet D, Patry I, Dupont P, Bize M, Jeannot K, Chavanet P, Plésiat P.

Pathol Biol (Paris). 2005 Oct-Nov;53(8-9):495-9. Epub 2005 Oct 3. French.


[Two efflux systems expressed simultaneously in clinical Pseudomonas aeruginosa].

Hocquet D, Llanes C, Patry I, El Garch F, Plésiat P.

Pathol Biol (Paris). 2004 Oct;52(8):455-61. French.


Supplemental Content

Support Center